Altria sees revenue decline in Q3, but its oral portfolio is on the rise

Altria posted a 4.7% revenue decline in the third quarter of the year, mainly driven by the continuing poor performance of its smokable segment but neutralised by the growth of its oral products in the US.

The Big Tobacco posted net revenues of $6.8bn in the period, while in the same period of 2020 it achieved $7.1bn. In the first nine months of the year, the company posted $19.7bn in revenues (+0.5%).